EIR Taro Pharmaceuticals Jul 2016

Steven Kehoe FDA$595.00 - Available Now

FDA investigators audited the Taro Pharmaceuticals - Brampton, Canada facility and issued inspectional observation (via FDA 483) on 29 Jul 2016.

Product details

  • Category:
  • Inspection end: 29 Jul 2016
  • Location: Brampton, Canada
  • FEI: 3002808384
Add To Cart